Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Frontiers in Oncology|August 21, 2024
Hyperthermia and radiotherapy: physiological basis for a synergistic effectMichael F Righini, André Durham, Pelagia G Tsoutsou
Frontiers in Oncology|November 6, 2024
Very early symptomatic metastasis pseudoprogression after stereotactic brain radiosurgery in a melanoma patient treated with BRAF/MEK inhibitors: a case report and review of the literatureEdouard Romano, Sebastien Tran, Assma Ben Aissa, et al.
Revue Medicale Suisse|May 17, 2024
[Treatment of localized rectal cancer in 2024]Nathalie Baudoux, Jeremy Meyer, André Durham, et al.
Cancers|July 12, 2025
Narrative Review: Predictive Biomarkers of Tumor Response to Neoadjuvant Radiotherapy or Total Neoadjuvant Therapy of Locally Advanced Rectal Cancer PatientsJoao Victor Machado Carvalho, Jeremy Meyer, Frederic Ris, et al.
Clinical Colorectal Cancer|September 20, 2025
Impact of Neoadjuvant Immunotherapy in Localized Rectal Cancer. A Systematic ReviewFlorian Salihu, Claudia Corro, Frédéric Ris, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|September 14, 2019
Novel inverse planning optimization algorithm for robotic radiosurgery: First clinical implementation and dosimetric evaluationMichele Zeverino, Maud Marguet, Cedric Zulliger, et al.
Revue Medicale Suisse|May 15, 2025
[Pancreatic cancer in 2025 : multidisciplinary management]Rita Brito, Sahar Mack, Aurélie Bornand, et al.
Haematologica|April 2, 2026
Azacitidine-induced remission enables allogeneic transplantation in TET2/BCOR-mutant relapsed extranodal natural killer/T-cell lymphoma: a case reportCarmen de Ramon Ortiz, Hana Abouzeid, Chiara De Bernardi, et al.
Iscience|January 19, 2026
Integrative analysis of transcriptomic data reveals a predictive gene signature for chemoradiotherapy response in rectal cancerClaudia Corrò, Joao Victor Machado Carvalho, Melivoia Rapti, et al.
BMC Cancer|July 15, 2022
Study protocol of a phase II study to evaluate safety and efficacy of neo-adjuvant pembrolizumab and radiotherapy in localized rectal cancerClaudia Corrò, Nicolas C Buchs, Matthieu Tihy, et al.
Pageof 2